Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/28013036http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28013036http://www.w3.org/2000/01/rdf-schema#comment"

Objective

To clarify the invasive mechanisms of muscle-invasive bladder cancer (BCa) would be useful for the determination of appropriate treatment strategies. We previously showed that hepatocyte growth factor (HGF)-MET signaling is correlated with invasiveness of BCa cells. Here, we investigated the effects of the MET inhibitor, cabozantinib (XL184), on BCa cells.

Methods

We first conducted Western blot analysis to investigate MET expression in BCa cell lines. Next, we examined the effect of cabozantinib on their proliferation and invasive abilities using MTT and Matrigel invasion assays, respectively. Invasion assays were performed using the xCELLigence system. Additionally, to investigate the biological function of HGF-MET signaling, we analyzed gene expression profiles and performed real-time polymerase chain reaction analyses of 5637 cells that were cultivated with or without HGF stimulation, with or without cabozantinib.

Results

MET was highly expressed in 4 of 5 BCa cell lines, and 5637 and T24 cells showed especially high protein expression of MET. Cabozantinib suppressed cell proliferation and invasion (cell index; mock, 1.49 vs HGF, 2.26 vs HGF + XL184, 1.47, P < .05). Gene expression profile analysis indicated that matrix metalloproteinase 1 (MMP1) was significantly elevated at the mRNA level with addition of HGF. Moreover, cabozantinib suppressed HGF-induced MMP1 expression in 5637 T24 cells.

Conclusions

These data indicate that cabozantinib suppressed MMP1 expression by blocking HGF-MET signaling and that HGF-MET-MMP1 signaling is involved in the invasiveness and proliferation of BCa cells. These results suggest that cabozantinib might prove useful for future treatment of muscle-invasive BCa."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.org/dc/terms/identifier"doi:10.1016/j.urology.2016.12.006"xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Mori H."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Takahashi M."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Yamamoto H."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Shintani T."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Nakatsuji H."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Kanayama H."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Fukumori T."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Kusuhara Y."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Fukawa T."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Daizumoto K."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/author"Dondoo T.O."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/name"Urology"xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/pages"169.e7-169.e13"xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/title"The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells."xsd:string
http://purl.uniprot.org/citations/28013036http://purl.uniprot.org/core/volume"101"xsd:string
http://purl.uniprot.org/citations/28013036http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28013036
http://purl.uniprot.org/citations/28013036http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28013036
http://purl.uniprot.org/uniprot/#_C9WSJ3-mappedCitation-28013036http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28013036
http://purl.uniprot.org/uniprot/#_C9WSJ4-mappedCitation-28013036http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28013036
http://purl.uniprot.org/uniprot/#_A5D6Q9-mappedCitation-28013036http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28013036
http://purl.uniprot.org/uniprot/#_A8K6K9-mappedCitation-28013036http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28013036
▶